Myovant Sciences Ltd MYOV:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 11/26/21 EST
19.25quote price arrow up+0.17 (+0.89%)
Close
19.08quote price arrow down-0.85 (-4.26%)
Volume
358,332
52 week range
16.69 - 30.90
Loading...
  • Open19.61
  • Day High20.25
  • Day Low18.85
  • Prev Close19.93
  • 52 Week High30.90
  • 52 Week High Date12/28/20
  • 52 Week Low16.69
  • 52 Week Low Date04/13/21

Key Stats

  • Market Cap1.757B
  • Shares Out92.08M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.82
  • YTD % Change-30.92

KEY STATS

  • Open19.61
  • Day High20.25
  • Day Low18.85
  • Prev Close19.93
  • 52 Week High30.90
  • 52 Week High Date12/28/20
  • 52 Week Low16.69
  • 52 Week Low Date04/13/21
  • Market Cap1.757B
  • Shares Out92.08M
  • 10 Day Average Volume0.42M
  • Dividend-
  • Dividend Yield-
  • Beta2.82
  • YTD % Change-30.92

RATIOS/PROFITABILITY

  • EPS (TTM)-2.62
  • P/E (TTM)-7.28
  • Fwd P/E (NTM)-9.40
  • EBITDA (TTM)-281.773M
  • ROE (TTM)-622.01%
  • Revenue (TTM)67.05M
  • Gross Margin (TTM)85.63%
  • Net Margin (TTM)-423.49%
  • Debt To Equity (MRQ)-89.76%

EVENTS

  • Earnings Date02/09/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Myovant Sciences Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Myovant Sciences Ltd. is a United Kingdom-based biopharmaceutical company focused on redefining care for women and for men through purpose-driven science, empowering medicines and transformative advocacy. The Company’s two products include ORGOVYX, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer; and MYFEMBREE, a once-daily oral treatment for the management of heavy menstrual bleeding...
Myrtle Potter
Chairman
David Marek
Chief Executive Officer
Uneek Mehra
Chief Financial Officer
Matthew Lang
General Counsel
Address
Ste 1 3rd Fl, 11/12 St. James's Square
London
SW1Y 4LB
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
NSTG
NanoString Technologies Inc
41.62-0.99-2.32%
VCEL
Vericel Corp
38.31-1.88-4.68%
GBT
Global Blood Therapeutics Inc
29.25-1.04-3.43%
XNCR
Xencor Inc
35.44-1.58-4.27%
BCRX
BioCryst Pharmaceuticals Inc
12.48-0.02-0.16%